Evidence map›Paper›PMID 35130722›Full record

ArticlemBio2021

Subcellular Detection of SARS-CoV-2 RNA in Human Tissue Reveals Distinct Localization in Alveolar Type 2 Pneumocytes and Alveolar Macrophages.

Kofi K Acheampong, Dylan L Schaff, Benjamin L Emert, Jonathan Lake, Sam Reffsin, Emily K Shea, Courtney E Comar, Leslie A Litzky, Nigar A Khurram, Rebecca L Linn and 5 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Kofi K AcheampongDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA.
Dylan L SchaffDepartment of Bioengineering, School of Engineering and Applied Science, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA.
Benjamin L EmertGenomics and Computational Biology Graduate Group, Perelman School of Medicine, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA.
Jonathan LakeDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA.
Sam ReffsinDepartment of Bioengineering, School of Engineering and Applied Science, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA.
Emily K SheaDepartment of Cancer Biology, Perelman School of Medicine, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA.
Courtney E ComarDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA.
Leslie A LitzkyDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA.
Nigar A KhurramDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA.
Rebecca L LinnDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA.
Michael FeldmanDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA.
Susan R WeissDepartment of Microbiology, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-8155-4528
Kathleen T MontoneDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA.
Sara CherryDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA.
Sydney M ShafferDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA.ORCID 0000-0003-3539-9886
University of Pennsylvania · USChildren's Hospital of Philadelphia · USPenn Center for AIDS Research · USNorthwestern University · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007170 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI BRASS, LAWRENCE F · 1985 to 2022
$54.0M
IMMUNOBIOLOGY OF NORMAL AND NEOPLASTIC LYMPHOCYTEST32CA009140 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Malay Haldar, WARREN S PEAR · 1985 to 2026
$16.1M
Training Program in Computational GenomicsT32HG000046 · NHGRI · UNIVERSITY OF PENNSYLVANIA · PI JUNHYONG KIM, Mingyao Li · 1999 to 2026
$9.5M
MERS coronavirus: antagonism of double-stranded RNA induced host response by accessory proteinsR01AI140442 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Susan R Weiss · 2018 to 2026
$5.1M
Defining the functional interface between the ER and flavivirusesR01AI140539 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI CHERRY, SARA, DIAMOND, MICHAEL S · 2018 to 2022
$3.0M
Defining the role of microbiota-derived cyclic dinucleotides in priming antiviral immune defenses.R01AI152362 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI CHERRY, SARA · 2020 to 2024
$2.0M
Decoding mechanisms of phenotypic memory in single cellsDP5OD028144 · OD · UNIVERSITY OF PENNSYLVANIA · PI SHAFFER, SYDNEY · 2019 to 2023
$2.0M
Rapid and highly sensitive influenza detection with RNA FISHF30AI114475 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI SHAFFER, SYDNEY · 2015 to 2017
$108k
Connecting molecular phenotype with cell fate using single-cell barcoding and RNA FISHF30CA236129 · NCI · UNIVERSITY OF PENNSYLVANIA · PI EMERT, BENJAMIN · 2019 to 2020
$59k
NCI NIH HHS F30 CA236129NCI NIH HHS T32 CA009140NHGRI NIH HHS T32 HG000046NIAID NIH HHS F30 AI114475NIAID NIH HHS R01 AI140442NIAID NIH HHS R01 AI140539NIAID NIH HHS R01 AI152362NIGMS NIH HHS T32 GM007170NIH HHS DP5 OD028144
6 · The paper itself

Abstract

The widespread coronavirus disease 2019 (COVID-19) is caused by infection with the novel coronavirus SARS-CoV-2. Currently, we have limited understanding of which cells become infected with SARS-CoV-2 in human tissues and where viral RNA localizes on the subcellular level. Here, we present a platform for preparing autopsy tissue for visualizing SARS-CoV-2 RNA using RNA fluorescence in situ hybridization (FISH) with amplification by hybridization chain reaction. We developed probe sets that target different regions of SARS-CoV-2 (including ORF1a and N), as well as probe sets that specifically target SARS-CoV-2 subgenomic mRNAs. We validated these probe sets in cell culture and tissues (lung, lymph node, and placenta) from infected patients. Using this technology, we observe distinct subcellular localization patterns of the ORF1a and N regions. In human lung tissue, we performed multiplexed RNA FISH HCR for SARS-CoV-2 and cell-type-specific marker genes. We found viral RNA in cells containing the alveolar type 2 (AT2) cell marker gene (

Indexed as

Alveolar Epithelial CellsCOVID-19HumansIn Situ Hybridization, FluorescenceLungMacrophages, AlveolarRNA, ViralSARS-CoV-2RNA, Viralcellular imagingfluorescent image analysisRNA FISHsingle cell

Identifiers

PMID35130722
PMCPMC8822351
OpenAlexW4210829650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.